|
Figure 1
(a) Preclinical component of a drug-discovery pipeline. (b) The wealth of data that is generated from a crystallographic fragment-screening campaign can inform both basic biology and drug discovery. |
Open
access

|
Figure 1
(a) Preclinical component of a drug-discovery pipeline. (b) The wealth of data that is generated from a crystallographic fragment-screening campaign can inform both basic biology and drug discovery. |